Open original FDA record ↗Recall record
- FDA identifier
- Z-1244-2022
- Company in FDA record
- Helena Laboratories, Corp.
- FDA record creation date
- Jun 7, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Due to microbial growth causing interference with interpretation.
Source facts
- Action
- On 04/06/2022, Helena Laboratories emailed an "URGENT MEDICAL DEVICE RECALL" Letter to customers informing them that the firm is recalling V8 Immunodisplacement Kit Lots 3-21-1803, and 1-22-1803 due to visible particulate contamination in some vials of a component within the kit - the IgG antisera. Use of this product may result in an artifact anodal to albumin potentially interfering with interpretation of the IgG pattern. Customers are instructed to immediately evaluate their inventory for product subject to recall, and quarantine accordingly. All unused bottles in the field will be removed from the field, and replaced with an unaffected lot. For questions or further assistance, email or call Dr. Jessica Jones Hanka at jhanka@helena.com or 1-800-231-5663 extension 1600.
- Initiated
- 2022-04-06
- Root cause
- Unknown/Undetermined by firm
- Distribution
- U.S.: FL, MO, OH, and TX O.U.S.: Canada, Uruguay, and Vietnam,
- Recall number
- Z-1244-2022
- Recall status
- Open, Classified
- CDRH record ID
- 193261
- FDA record created
- 2022-06-07
- Recall event number
- 90060